HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RIBOLIFE-B

61.800

-2.100-3.29%

Volume:127.85K

Turnover:8.11M

Market Cap:10.51B

PE:-29.43

High:67.000

Open:67.000

Low:61.050

Close:63.900

52wk High:95.800

52wk Low:43.600

Shares:170.00M

HK Float Shares:170.00M

Volume Ratio:0.19

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.100

ROE:-17.59%

ROA:-3.85%

PB:5.22

PE(LYR):-29.43

PS:19.42

Loading ...

Overview Company News Filings

RIBOLIFE-B (06938) Allocates HK$306,900 for Share Buyback on July 15

Suzhou Ribo Files HKEX Next-day Disclosure After Share Repurchase

Ribo Life Science executes HK$9.30 million on-market repurchase of 186,600 H shares

Bulletin Express

Suzhou Ribo Files HKEX Next-day Return Disclosing Share Buyback at HKD 49.85 Average Price

RIBOLIFE-B (06938) Repurchases 186,600 H-Shares on July 13 for HK$9.3012 Million

RIBOLIFE-B Shares Surge Nearly 5% in Afternoon Session, Securing "Buy" Rating from China Post Securities

Ribo Life Science executive Dr. Gan Liming lifts personal stake by 6,800 H shares, cumulative purchase reaches 20,000 shares

Bulletin Express

RIBOLIFE-B Executive Director Acquires Additional H Shares

Suzhou Ribo Director Gan Liming Lifts H-share Stake with 6,800-share Purchase

Suzhou Ribo Life Science Co - Co-ceo Purchases 6800 H Shares on Open Market

THOMSON REUTERS

Suzhou Ribo Life Science Co's Co-ceo Purchases 13,200 H Shares of Co

CMSC International Initiates Coverage on RIBOLIFE-B, Adding to Top Picks with HK$105 Target

Suzhou Ribo Life Science Co - Co-ceo Purchases 13,200 H Shares of Suzhou Ribo Life Science

THOMSON REUTERS

RIBOLIFE-B Shares Surge Over 6% on Milestone Achievement in siRNA Collaboration with Madrigal

RIBOLIFE-B and MADRIGAL Achieve First Key Milestone in siRNA Collaboration

Suzhou Ribo Hits First Milestone in Madrigal Sirna Collaboration for MASH Drug Candidate

Suzhou Ribo Life Science to Buy 25.93% Stake in Azemidite

RIBOLIFE-B to Acquire Additional Stake in Subsidiary, Increasing Ownership to Approximately 88.17%

Suzhou Ribo Life Science Co Ltd - Deal for RMB70 Mln

THOMSON REUTERS

CMSC Initiates Coverage on RIBOLIFE-B with 'Add' Rating and HK$105 Price Target

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/06938/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06938","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06938\",,,,,undefined,":{"symbol":"06938","market":"HK","secType":"STK","nameCN":"RIBOLIFE-B","latestPrice":61.8,"timestamp":1787904511922,"preClose":63.9,"halted":0,"volume":127851,"delay":0,"changeRate":-0.03286384976525824,"floatShares":170000000,"shares":170000000,"eps":-2.100221,"marketStatus":"Not Yet Opened","change":-2.1,"latestTime":"08-28 16:08:31","open":67,"high":67,"low":61.05,"amount":8114845,"amplitude":0.093114,"askPrice":61.8,"askSize":600,"bidPrice":61.5,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-1.805,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":0,"adr":0,"listingDate":1767888000000,"exchange":"SEHK","adjPreClose":63.9,"openAndCloseTimeList":[[1787880600000,1787889600000],[1787893200000,1787904000000]],"volumeRatio":0.19208256438690646,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06938\",,,,,undefined,":{"symbol":"06938","floatShares":170000000,"roa":"-3.85%","roe":"-17.59%","lyrEps":-2.100221,"volumeRatio":0.19208256438690646,"shares":170000000,"dividePrice":0,"high":67,"amplitude":0.093114,"preClose":63.9,"low":61.05,"week52Low":43.6,"pbRate":"5.22","psRate":"19.42","week52High":95.8,"institutionHeld":0,"latestPrice":61.8,"committee":0.538462,"eps":-2.100221,"divideRate":0,"volume":127851,"delay":0,"ttmEps":-1.805,"open":67,"prevYearClose":57.97,"prevWeekClose":61.8,"prevMonthClose":47.16,"prevQuarterClose":46.9,"fiveDayClose":53.4,"twentyDayClose":47.16,"sixtyDayClose":54.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06938\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"06938","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"market":"HK","date":"2026-03-25","symbol":"06938","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774368000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06938\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06938\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1784304000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06938\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06938","date":"2026-08-28","current":-34.238227,"percent":0,"low":-53.27383,"twenty":-37.770699,"median":-30.842167,"eighty":-26.562391,"high":-23.913403,"avg":-32.410788,"sd":6.666018,"marketCap":10540293438},"quantilePoints":[{"date":"2026-02-13","current":-47.784644,"twenty":-49.967526,"median":-49.148945,"eighty":-48.330365,"marketCap":11947371445},{"date":"2026-02-20","current":-49.493094,"twenty":-49.901155,"median":-49.02522,"eighty":-48.248265,"marketCap":12356703229},{"date":"2026-02-27","current":-46.28708,"twenty":-49.778496,"median":-48.557346,"eighty":-47.185619,"marketCap":11683011335},{"date":"2026-03-06","current":-41.043234,"twenty":-48.963884,"median":-47.035862,"eighty":-41.420692,"marketCap":10275933327},{"date":"2026-03-13","current":-37.939269,"twenty":-48.578839,"median":-43.677981,"eighty":-39.627323,"marketCap":9542547214},{"date":"2026-03-20","current":-38.832211,"twenty":-48.543939,"median":-40.85279,"eighty":-39.405242,"marketCap":9730157615},{"date":"2026-03-27","current":-30.985978,"twenty":-48.084787,"median":-40.112534,"eighty":-38.372934,"marketCap":9755740852},{"date":"2026-04-02","current":-34.881193,"twenty":-47.185618,"median":-39.757485,"eighty":-36.526858,"marketCap":11034902677},{"date":"2026-04-10","current":-37.770699,"twenty":-46.28708,"median":-39.613953,"eighty":-36.479378,"marketCap":12041176646},{"date":"2026-04-17","current":-35.241421,"twenty":-45.408639,"median":-38.832211,"eighty":-35.918978,"marketCap":11239568569},{"date":"2026-04-24","current":-33.421304,"twenty":-43.677981,"median":-38.300657,"eighty":-35.241421,"marketCap":10659681875},{"date":"2026-04-30","current":-32.557368,"twenty":-42.07346,"median":-37.836456,"eighty":-34.614071,"marketCap":10386794019},{"date":"2026-05-08","current":-32.498031,"twenty":-41.169053,"median":-37.354591,"eighty":-33.058756,"marketCap":10403849510},{"date":"2026-05-15","current":-32.120533,"twenty":-40.738524,"median":-36.586666,"eighty":-32.493391,"marketCap":10310044309},{"date":"2026-05-22","current":-30.090442,"twenty":-40.591323,"median":-35.918978,"eighty":-32.095834,"marketCap":9636352415},{"date":"2026-05-29","current":-30.88841,"twenty":-40.296947,"median":-35.448939,"eighty":-31.691849,"marketCap":9926295762},{"date":"2026-06-05","current":-28.193848,"twenty":-40.051892,"median":-35.061307,"eighty":-30.899503,"marketCap":9073521212},{"date":"2026-06-12","current":-27.046231,"twenty":-39.859077,"median":-34.61525,"eighty":-30.390832,"marketCap":8698300410},{"date":"2026-06-18","current":-26.187923,"twenty":-39.726813,"median":-33.720381,"eighty":-29.853022,"marketCap":8442468045},{"date":"2026-06-26","current":-23.913403,"twenty":-39.627323,"median":-32.945231,"eighty":-29.564677,"marketCap":7671559851},{"date":"2026-07-03","current":-27.120201,"twenty":-39.476172,"median":-32.527699,"eighty":-28.324896,"marketCap":8706828155},{"date":"2026-07-10","current":-25.658884,"twenty":-39.120404,"median":-32.474833,"eighty":-27.529192,"marketCap":8227568858},{"date":"2026-07-17","current":-25.917703,"twenty":-38.802803,"median":-32.09845,"eighty":-26.657872,"marketCap":8340135099},{"date":"2026-07-24","current":-28.402389,"twenty":-38.680546,"median":-32.07594,"eighty":-26.891702,"marketCap":9141743176},{"date":"2026-07-31","current":-24.94248,"twenty":-38.662044,"median":-31.566896,"eighty":-26.553964,"marketCap":8043369555},{"date":"2026-08-07","current":-27.580979,"twenty":-37.939269,"median":-30.913769,"eighty":-26.515913,"marketCap":8911494047},{"date":"2026-08-14","current":-27.888785,"twenty":-37.902214,"median":-30.842167,"eighty":-26.553964,"marketCap":9022354739},{"date":"2026-08-21","current":-28.090305,"twenty":-37.770699,"median":-30.35874,"eighty":-26.553964,"marketCap":9107632194},{"date":"2026-08-28","current":-53.27383,"twenty":-37.770699,"median":-30.842167,"eighty":-26.562391,"marketCap":10540293438}],"updateTime":1788093112114},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06938\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1155049285","title":"RIBOLIFE-B (06938) Allocates HK$306,900 for Share Buyback on July 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1155049285","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155049285?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:14","pubTimestamp":1784114056,"startTime":"0","endTime":"0","summary":"On July 15, 2026, RIBOLIFE-B (ASX: 06938) executed a share repurchase, utilizing HK$306,900 to acquire 6,200 of its own shares.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651457540","title":"Suzhou Ribo Files HKEX Next-day Disclosure After Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2651457540","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651457540?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:11","pubTimestamp":1784113909,"startTime":"0","endTime":"0","summary":"Suzhou Ribo files HKEX next-day disclosure after share repurchaseSuzhou Ribo repurchased 6,200 H shares on July 15, held as treasury shares; no shares were repurchased for cancellation.Buyback execute","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL46kJkJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181401404","title":"Ribo Life Science executes HK$9.30 million on-market repurchase of 186,600 H shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1181401404","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181401404?lang=en_us&edition=fundamental","pubTime":"2026-07-13 22:06","pubTimestamp":1783951583,"startTime":"0","endTime":"0","summary":"Ribo Life Science (Suzhou Ribo Life Science Co., Ltd.) disclosed that it bought back 186,600 H shares on 13 July 2026 under its existing shareholder-approved mandate. The transaction totalled HK$9.30...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651217112","title":"Suzhou Ribo Files HKEX Next-day Return Disclosing Share Buyback at HKD 49.85 Average Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2651217112","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651217112?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:54","pubTimestamp":1783950892,"startTime":"0","endTime":"0","summary":"Suzhou Ribo files HKEX next-day return disclosing share buyback at HKD 49.85 average priceSuzhou Ribo Life Science filed a next-day disclosure return reporting a repurchase of 186,600 H shares on July","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL6jGHbb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159820551","title":"RIBOLIFE-B (06938) Repurchases 186,600 H-Shares on July 13 for HK$9.3012 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1159820551","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159820551?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:52","pubTimestamp":1783950737,"startTime":"0","endTime":"0","summary":"On July 13, RIBOLIFE-B (ASX: 06938) disclosed its share repurchase activity for the day. The company acquired a total of 186,600 H-shares in the open market. The total expenditure for this transaction amounted to HK$9.3012 million. All the repurchased H-shares are being held as treasury stock.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128833810","title":"RIBOLIFE-B Shares Surge Nearly 5% in Afternoon Session, Securing \"Buy\" Rating from China Post Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1128833810","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128833810?lang=en_us&edition=fundamental","pubTime":"2026-07-13 14:50","pubTimestamp":1783925442,"startTime":"0","endTime":"0","summary":"Shares of RIBOLIFE-B (06938) rose more than 6% during the trading session. At the time of writing, the stock is up 4.69%, trading at HK$50.50 with a turnover of HK$15.096 million. RIBOLIFE-B issued...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06938","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138010880","title":"Ribo Life Science executive Dr. Gan Liming lifts personal stake by 6,800 H shares, cumulative purchase reaches 20,000 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1138010880","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138010880?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:23","pubTimestamp":1783678987,"startTime":"0","endTime":"0","summary":"Suzhou Ribo Life Science Co., Ltd. (Ribo Life Science) disclosed that executive director, co-chief executive officer and global R&D president Dr. Gan Liming bought 6,800 H shares of the company on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102637458","title":"RIBOLIFE-B Executive Director Acquires Additional H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1102637458","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102637458?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:22","pubTimestamp":1783678939,"startTime":"0","endTime":"0","summary":"RIBOLIFE-B (ASX: 06938) has announced that the company's board was recently informed by Dr. Gan Liming, an executive director, co-CEO, and global head of R&D, that he has used personal funds to...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650181928","title":"Suzhou Ribo Director Gan Liming Lifts H-share Stake with 6,800-share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2650181928","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650181928?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:18","pubTimestamp":1783678692,"startTime":"0","endTime":"0","summary":"Suzhou Ribo director Gan Liming lifts H-share stake with 6,800-share purchaseExecutive director Gan Liming bought 6,800 H shares on-market, lifting his cumulative purchases to 20,000 H shares as of Ju","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL8vqqXr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Suzhou Ribo Director Gan Liming Lifts H-share Stake with 6,800-share Purchase","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650819401","title":"Suzhou Ribo Life Science Co - Co-ceo Purchases 6800 H Shares on Open Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2650819401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650819401?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:18","pubTimestamp":1783678682,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C0K0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649983876","title":"Suzhou Ribo Life Science Co's Co-ceo Purchases 13,200 H Shares of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2649983876","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649983876?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:47","pubTimestamp":1783414046,"startTime":"0","endTime":"0","summary":"July 3 (Reuters) - Suzhou Ribo Life Science Co Ltd <6938.HK>::*CO-CEO PURCHASES 13,200 H SHARES OF SUZHOU RIBO LIFE SCIENCE*Further company coverage: 6938.HK* ((Reuters.Briefs@thomsonreuters.com;))((R","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nRSD19bMPT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183406159","title":"CMSC International Initiates Coverage on RIBOLIFE-B, Adding to Top Picks with HK$105 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1183406159","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183406159?lang=en_us&edition=fundamental","pubTime":"2026-07-06 11:32","pubTimestamp":1783308760,"startTime":"0","endTime":"0","summary":"CMSC International has released a research report initiating coverage on RIBOLIFE-B (06938) and adding it to its list of preferred stock picks. The firm believes the company holds a differentiated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","BK1147","06099","BK1564","06938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648689716","title":"Suzhou Ribo Life Science Co - Co-ceo Purchases 13,200 H Shares of Suzhou Ribo Life Science","url":"https://stock-news.laohu8.com/highlight/detail?id=2648689716","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648689716?lang=en_us&edition=fundamental","pubTime":"2026-07-03 18:22","pubTimestamp":1783074120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nFWN4340ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165975363","title":"RIBOLIFE-B Shares Surge Over 6% on Milestone Achievement in siRNA Collaboration with Madrigal","url":"https://stock-news.laohu8.com/highlight/detail?id=1165975363","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165975363?lang=en_us&edition=fundamental","pubTime":"2026-07-02 11:52","pubTimestamp":1782964343,"startTime":"0","endTime":"0","summary":"Shares of RIBOLIFE-B (06938) rose more than 6% in the morning session. At the time of writing, the stock was up 5.49% to HK$11.33, with a turnover of HK$17.38 million. The company announced on July...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1161","BK4585","BK4588","06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186587424","title":"RIBOLIFE-B and MADRIGAL Achieve First Key Milestone in siRNA Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=1186587424","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186587424?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:26","pubTimestamp":1782951980,"startTime":"0","endTime":"0","summary":"RIBOLIFE-B has announced the achievement of the first candidate drug selection milestone in its siRNA collaboration project with Madrigal Pharmaceuticals.This partnership is focused on advancing...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648522050","title":"Suzhou Ribo Hits First Milestone in Madrigal Sirna Collaboration for MASH Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2648522050","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648522050?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:01","pubTimestamp":1782950511,"startTime":"0","endTime":"0","summary":"Suzhou Ribo hits first milestone in Madrigal siRNA collaboration for MASH drug candidateSuzhou Ribo Life Science reached a first candidate drug nomination milestone in its siRNA partnership with Madri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL6QTG1Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","06938","BK1161","BK4139","MDGL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648681905","title":"Suzhou Ribo Life Science to Buy 25.93% Stake in Azemidite","url":"https://stock-news.laohu8.com/highlight/detail?id=2648681905","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648681905?lang=en_us&edition=fundamental","pubTime":"2026-07-01 00:01","pubTimestamp":1782835278,"startTime":"0","endTime":"0","summary":"BRIEF-Suzhou Ribo Life Science To Buy 25.93% Stake In AzemiditeJune 30 (Reuters)-Suzhou Ribo Life Science Co Ltd6938.HK:TO BUY 25.93% EQUITY INTEREST IN AZEMIDITEDEAL FOR RMB70 MILLIONFurther company coverage:6938.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nFWN4320VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121370878","title":"RIBOLIFE-B to Acquire Additional Stake in Subsidiary, Increasing Ownership to Approximately 88.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121370878","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121370878?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:40","pubTimestamp":1782830443,"startTime":"0","endTime":"0","summary":"The company, RIBOLIFE-B (ASX: 06938), has announced the signing of a share transfer agreement with Haihe Cathay Fund. Under this agreement, the company will acquire a 25.93% equity interest in its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647521825","title":"Suzhou Ribo Life Science Co Ltd - Deal for RMB70 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2647521825","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647521825?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:31","pubTimestamp":1782829878,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nFWN4320VG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177506769","title":"CMSC Initiates Coverage on RIBOLIFE-B with 'Add' Rating and HK$105 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1177506769","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177506769?lang=en_us&edition=fundamental","pubTime":"2026-06-22 15:18","pubTimestamp":1782112702,"startTime":"0","endTime":"0","summary":"CMSC International has released a research report initiating coverage on RIBOLIFE-B (06938) with an \"Add\" rating and a target price of HK$105. The firm is optimistic about the company's core asset,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06099","BK1161","BK1564","EWH","BK1147","06938"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":96,"code":"91000000","status":"200"}]}}